Samir Kaul is Director at Guardant Health, Inc. (GH). They have made 7 open-market trades across 1 company since 2011, most recently 2023-06-14.
CIK 0001501915
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GH | SELL | 2021-05-05 | 2021-05-07 | $142.49 | $1.1M | -13.9% | -12.4% | -13.2% |
| GH | SELL | 2021-04-05 | 2021-04-07 | $158.84 | $1.3M | -4.3% | -15.3% | -22.3% |
| GH | SELL | 2020-10-16 | 2020-10-20 | $101.88 | $2.0M | +4.7% | +6.5% | +57.1% |
| GH | SELL | 2020-09-17 | 2020-09-21 | $100.82 | $1.8M | +1.6% | -6.4% | +21.7% |
| GH | SELL | 2020-08-17 | 2020-08-19 | $87.57 | $1.7M | +5.1% | +12.8% | +17.2% |
| GH | SELL | 2020-03-04 | 2020-03-06 | $82.38 | $2.1M | -13.9% | -7.0% | +14.8% |
| GH | SELL | 2019-11-21 | 2019-11-25 | $79.05 | $4.3M | -7.8% | +2.1% | +5.0% |
| AMRS | SELL · 10b5-1 | 2011-10-12 | 2011-10-14 | $16.36 | $273K | -23.7% | -6.5% | -6.5% |
| AMRS | SELL · 10b5-1 | 2011-09-13 | 2011-09-15 | $18.00 | $300K | -23.7% | -6.5% | -6.5% |
| AMRS | SELL · 10b5-1 | 2011-08-12 | 2011-08-16 | $19.94 | $133K | -23.7% | -6.5% | -6.5% |
| AMRS | SELL · 10b5-1 | 2011-07-12 | 2011-07-14 | $27.33 | $182K | -23.7% | -6.5% | -6.5% |
| AMRS | SELL · 10b5-1 | 2011-06-13 | 2011-06-15 | $28.54 | $286K | -23.7% | -6.5% | -6.5% |
| AMRS | SELL · 10b5-1 | 2011-05-12 | 2011-05-16 | $25.83 | $172K | -23.7% | -6.5% | -6.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.